Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
United States | Publication | November 5, 2021
Federal OSHA published today in the Federal Register its "Emergency Temporary Standard (ETS) to protect more than 84 million workers from the spread of the coronavirus." We provide here the OSHA FAQs documents highlighting the critical provisions and requirements of the ETS.
The ETS compels covered employers to develop and enforce a mandatory COVID vaccination policy unless they adopt a policy requiring employees to choose either vaccination or weekly COVID testing and masking at work.
The ETS covers employers with 100 or more employees – firm- or company-wide – and provides options for compliance. It also requires employers to provide paid time to workers to get vaccinated and paid leave to recover from side effects.
Moreover, the ETS requires employers to:
The ETS does not require employers to pay for testing or face coverings, although employers may be required to pay for testing to comply with other laws, regulations or collective bargaining agreements.
OSHA is offering compliance assistance to implement the standard.
Employers must comply with most ETS requirements within 30 days of today's publication, and within 60 days for testing requirements.
We will report separately on the numerous constitutional and other legal challenges being filed by the multiple states' Attorneys General and business organizations to invalidate the ETS.
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
The ongoing conflicts and further geopolitical tensions in Eastern Europe and the Middle East, coupled with upcoming elections in a number of key countries including the US and the UK, make 2024 challenging to predict what impact this will have on the insurance sector.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023